Yttrium 90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Produces High Response Rates and Durable Remissions in Patients with Previously Treated B-Cell LymphomaLeo I. Gordon, Christine A. White, Arturo Molina et al.|Clinical Lymphoma|2004Cited by 121